Issue 2/2016
Content (18 Articles)
Pituitary metastasis: is there still a place for neurosurgical treatment?
V. Gilard, C. Alexandru, F. Proust, S. Derrey, P. Hannequin, O. Langlois
Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors
Marie Morfouace, Birgit Nimmervoll, Nidal Boulos, Yogesh T. Patel, Anang Shelat, Burgess B. Freeman III, Giles W. Robinson, Karen Wright, Amar Gajjar, Clinton F. Stewart, Richard J. Gilbertson, Martine F. Roussel
Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells
Rong Zhang, Ryuta Saito, Ichiyo Shibahara, Shinichiro Sugiyama, Masayuki Kanamori, Yukihiko Sonoda, Teiji Tominaga
Tumor location, but not H3.3K27M, significantly influences the blood–brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma
Ergys Subashi, Francisco J. Cordero, Kyle G. Halvorson, Yi Qi, John C. Nouls, Oren J. Becher, G. Allan Johnson
AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models
Edwin Chang, Christoph Pohling, Arutselvan Natarajan, Timothy H. Witney, Jasdeep Kaur, Lingyun Xu, Gayatri Gowrishankar, Aloma L D’Souza, Surya Murty, Sophie Schick, Liyin Chen, Nicholas Wu, Phoo Khaw, Paul Mischel, Taher Abbasi, Shahabuddin Usmani, Parag Mallick, Sanjiv S. Gambhir
Association between RAD 51 rs1801320 and susceptibility to glioblastoma
S. Franceschi, S. Tomei, C. M. Mazzanti, F. Lessi, P. Aretini, M. La Ferla, V. De Gregorio, F. Pasqualetti, K. Zavaglia, G. Bevilacqua, A. G. Naccarato
Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma
Ersoy Oksuz, Fatmahan Atalar, Gamze Tanırverdi, Ayahan Bilir, Andleeb Shahzadi, Zeliha Yazici
Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival
Valeria Cuccarini, A. Erbetta, M. Farinotti, L. Cuppini, F. Ghielmetti, B. Pollo, F. Di Meco, M. Grisoli, G. Filippini, G. Finocchiaro, M. G. Bruzzone, M. Eoli
Leukoencephalopathy in long term brain metastases survivors treated with radiosurgery
Or Cohen-Inbar, Patrick Melmer, Cheng-chia Lee, Zhiyuan Xu, David Schlesinger, Jason P. Sheehan
Impact of cognitive function on communication in patients with primary or secondary brain tumours
Diana N. Naehrig, Eng-Siew Koh, Monica Vogiatzis, Waka Yanagisawa, Carol Kwong, Heather L. Shepherd, Chris Milross, Haryana M. Dhillon
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
H. Ian Robins, Peixin Zhang, Mark R. Gilbert, Arnab Chakravarti, John F. de Groot, Sean A. Grimm, Fen Wang, Frank S. Lieberman, Andra Krauze, Andy M. Trotti, Nimish Mohile, Andrew Y. J. Kee, Howard Colman, Robert Cavaliere, Santosh Kesari, Steven J. Chmura, Minesh Mehta
Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI
Edit Bosnyák, David O. Kamson, Natasha L. Robinette, Geoffrey R. Barger, Sandeep Mittal, Csaba Juhász
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933
Chip Caine, Snehal Deshmukh, Vinai Gondi, Minesh Mehta, Wolfgang Tomé, Benjamin W. Corn, Andrew Kanner, Howard Rowley, Vijayananda Kundapur, Albert DeNittis, Jeffrey Noah Greenspoon, Andre A. Konski, Glenn S. Bauman, Adam Raben, Wenyin Shi, Merideth Wendland, Lisa Kachnic
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey
Tobias Walbert, Michael Glantz, Lonni Schultz, Vinay K. Puduvalli
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
Johan A. F. Koekkoek, Linda Dirven, Jan J. Heimans, Tjeerd J. Postma, Maaike J. Vos, Jaap C. Reijneveld, Martin J. B. Taphoorn
Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab
C. Frenard, L. Peuvrel, M. Saint Jean, A. Brocard, A. C. Knol, J. M. Nguyen, A. Khammari, G. Quereux, B. Dreno
Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma
Julia Tichy, Sabrina Spechtmeyer, Michel Mittelbronn, Elke Hattingen, Johannes Rieger, Christian Senft, Christian Foerch
Pediatric brain tumors in a low/middle income country: does it differ from that in developed world?
Sameera Ezzat, Mohamed Kamal, Nada El-Khateeb, Mohamed El-Beltagy, Hala Taha, Amal Refaat, Madeha Awad, Sherif Abouelnaga, Mohamed Saad Zaghloul